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PURPOSE. The purpose of this study was to develop a convenient test of stereopsis in the clinic
that is both robust and reliable and capable of providing a measure of variability necessary to
make valid comparisons between measurements obtained at different occasions or under
different conditions.
METHODS. Stereo acuity was measured based on principles derived from the laboratory
measurement of stereopsis (i.e., staircase method). Potential premeasurement compensations
are described if there is a significant degree of ocular misalignment, reduced visual acuity, or
aniseikonia. Forty-six adults at McGill University, 44 adults at Auckland University, and 51
adults from the University of Bradford, with an age range of 20 to 65 years old and normal or
corrected-to-normal vision participated in this study.
RESULTS. Stereo acuity within this normal population was widely distributed, with a significant
percentage (28%) of the population with only coarse stereo (>300 arc seconds). Across
subjects, the SD was approximately 25% of the mean. Measurements at two different times
were strongly (r ¼ 0.79) and significantly (P < 0.001) correlated, with little to no significant
(P ¼ 0.79) bias (0.01) between test and retest measures of stereopsis.
CONCLUSIONS. The application enables measurements over the wide disparity range and not
just at the finest disparities. In addition, it allows changes in stereopsis of the order of 1.9 to
be statistically distinguished.
Keywords: clinic, stereoacuity, iPod
The primate visual system derives considerable benefit fromthe overlapping visual fields of the two eyes as a
consequence of front facing eyes. Binocular vision in general
and stereopsis in particular are fundamental to human vision
and visual actions. When binocularity is disrupted early in life
due to a strabismus, anisometropia, or a monocular opacity or
ptosis, vision can be compromised in the affected eye and
stereopsis lost.1 Hand–eye coordination is disrupted,2–5 and
self-esteem,6 life style,7 and career choices are greatly affected.
A number of modern approaches to amblyopia therapy set out
to restore binocular function as a top priority,8–16 and their
primary outcome measure is ideally binocular fusion and
stereopsis rather than monocular acuity. Although these new
therapies, unlike the more traditional patching, have been
shown to be effective in adults9–12,14–16 and children,8,9,13 there
is no reliable way to document these changes in stereoscopic
performance clinically. The overall goal of this study was to
provide a reliable and convenient method with which stereo
could be measured in the clinic.
At present, there are no tests for stereopsis that are robust in
terms of being able to adequately sample a wide disparity
range17 and provide a measure of measurement variability.18
The present book tests were primarily designed for children,19
and they are coarsely quantized, only involve disparity
increments, and have a restricted range (20–800 arc seconds).
They are certainly adequate for screening, but because each
disparity level is often presented only once, they can not
provide any measure of variability, something that is needed to
address the significance of a change in stereo performance of a
clinical population as a result of an intervention, for example, a
clinical trial. What we do know is that the test–retest reliability
of the present book tests is such that a factor of 4 in stereopsis
has to occur for an individual for it to be classified as
significant.18 However, the individual test–retest reliability is a
crude way for assessing changes in performance at an
individual level because it derives its estimate of variability
from population statistics and not the actual variability
associated with an individual measurement. To provide a more
accurate statistical evaluation of whether two means are
different, the iPod stereo test described here, unlike the
current clinical book tests, supplies a measure of the variability
associated with each measurement.
Here, we describe a new clinically convenient method of
measuring stereopsis in adults using a handheld device. This
random dot stereo test is accurate, being based on a standard
psychophysical procedure; it provides a measure of variability
because multiple trials are presented at each disparity; and it
allows a wider disparity range to be tested without quantiza-
tion. We demonstrate its use in three vision departments: one
ophthalmological and two optometric. We show that, in the
normal population, stereoscopic function is widely distributed,
with a significant percentage of the population with only
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coarse stereo. This corroborates the findings of an earlier study
with a larger sample size using a different but comparable web-
based approach.20 We point out two caveats with regard to the
clinical measurement of stereopsis: one being unequal acuity
in the two eyes, something well recognized within the clinical
fraternity,21 and the other being unequal image size in the two
eyes, something often neglected. We provide a measure of the
influence of each of these commonly occurring factors. A
compensation for aniseikonia is inbuilt into the current test so
that a measure of stereo capability can be obtained that is not




Forty-six adults at McGill University, 44 adults at Auckland
University, and 51 adults from the University of Bradford, with
normal or corrected-to-normal (0 logMAR or better) monocular
vision participated in this study. The subjects were either staff
(clinicians or ancillary) or students at each eye center, and the age
range was wide (20–65 years old). An informed consent form was
obtained prior to the study, which was approved by the
Institutional Review Board of McGill University, the Institutional
Review Board of Auckland University, and the Institutional Review
Board of the University of Bradford. The described research
adhered to the tenets of the Declaration of Helsinki. Except the
authors, all subjects were naive to the purpose of this study.
Apparatus and Stimulus
The measurement was conducted by a Mac iPod (model
A1367; Apple, Inc., Cupertiono, CA, USA) running the
Stereogram Test app, an in-house software for Apple’s mobile
operating system (IOS) devices that feature 326 pixels per inch
(ppi) retina displays (background luminance was zero; i.e.,
black). The app software was written in Objective-C using the
IOS software development kit combined with OpenGL ES 2.0.
Observers viewed the stimuli dichoptically through red–green
anaglyph glasses at a viewing distance of 50 cm in an
environment with normal interior lighting.
Stimuli were two side-by-side static random-dot disks on a
dark background, as shown in Figure 1A. The disks were
FIGURE 1. Illustration of the Stereogram Test app. (A) The 3D stimuli. Observers were asked to answer which disk was behind the screen by taping
its position. (B) The test settings. (C) An example of the results from one staircase estimate.
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Gaussian-windowed to blend the edge to the background. Each
disk contained randomly positioned red and green dots, which
had a certain offset to generate depth perception (i.e.,
disparity). Overlapped red and green dots (or overlapped
parts of dots, determined by the size of the dots) were blended
into an orange color by using the blending functions provided
by OpenGL ES to provide subpixel resolution.
The offsets between red and green dots were equal and
opposite in the two disks; thus, one of the two disks would be
perceived as in front of the screen plane and the other behind
the screen plane. In each trial, the observers’ task was to tap
the disk that was perceived to be behind the screen plane.
There was no time limit for responding, as the next trial came
immediately after the observers’ response.
Procedure
Observers were asked to finish a 10-trial practice before the
test. After that, a 5-minute test session, incorporating two
separate runs, was used to estimate individuals’ stereo
thresholds. Each run was driven by a staircase procedure in
which the initial offset between red and green dots was set to
40 pixels (corresponding to a stereo acuity of 21.79 arc
minutes) and was controlled by a two-down/one-up staircase
procedure thereafter. The initial step size was 50%, which
changed after the first reversal to 10% in all following trials.
Because all of our participants were normal adults, we
artificially set the maximal offset between red and green dots
to 40 pixels to ensure that it was less than Dmax (which was
approximately 104 arc seconds).22 The staircase was terminat-
ed at the fourth reversal point. The stereo threshold and its SE
and SD were then calculated based on the last three reversals
averaged across in the two test runs (i.e., six reversals in total).
Potential Test Configuration
As shown in Figure 1B, the following configurable parameters
were provided in the Stereogram Test app:
1. Visual acuity of the worse eye: This was recorded in
logMAR (near distance 50 cm) on the iPod, and a
nomogram was provided to estimate what loss in stereo
was expected based on the acuity of the worse eye. To
assess the effects of lens blur on stereo using this test,
two subjects viewed the iPod test with add-on lenses in
front of the right eye (2.50–3.00 diopters [D]), which,
accounting for the testing distance of 50 cm (i.e., 2.00
D), resulted in a lens blur of between 0.50 and 1.00 D.
2. Aniseikonia: To account for an image size difference due,
for example, to spectacle-corrected anisometropia, the
size of the pixels could be scaled in front of the more
emmetropic eye. A second program was incorporated
within this app to measure the degree of aniseikonia. To
assess the potential impact of aniseikonia, two subjects
undertook the stereo test in which the pixels in one
eye’s view were scaled in the region of 0% to 20%.
3. Visual alignment: In case of ocular misalignment (e.g.,
strabismus), an alignment calibration feature can be
implemented to allow fusion of the two eyes’ images.
During the alignment, two half-crosses (one in red and
the other one in green) were dichoptically presented to
the two eyes. Observers can be asked to align the two
half-cross into a perfect whole cross. The degree to
which the alignment was stable from run to run can be
then assessed, as the alignment offset is provided to the
examiner.
4. Repeat times: Participants were allowed to repeat
individual test runs in a test session if the staircase
results was clearly of an anomalous form indicative of a
poor determination as the result of, for example, an
early response mistake (finger error).
All the subjects tested in this study had normal visual acuity
in each eye, no aniseikonia, and no misalignment of the eyes.
These features are described so that the implementation of this
test within a clinical population can be assessed.
Result Transformation
As shown in Figure 1C, a plot of disparity as a function of trial
number is provided for each test run on completion of the test.
The disparity was recorded in pixels during the measurement








where n is the offsets between the red and green dots (in
pixels), Wpixel is the physical width of a pixel on the display,
and D is the distance between the subject’s eyes and device’s
display. In our study, Wpixel was 0.0792 mm and D was 500
mm.
RESULTS
The basic result is seen in Figure 2 where we have plotted the
results across the three institutions as a bar graph showing the
distribution of stereopsis (log seconds of arc) in the normal
population sample. The results are not normally distributed,23
and it is clear that the distribution is broad. Some subjects have
relatively good stereo, and others have relatively poor stereo.
Approximately 13% of our subjects reached the ceiling offset of
40 pixels (1307 arc seconds) as reflected in the histogram bar
corresponding to the largest disparity. This was an order of
magnitude below Dmax for these stimulus conditions,
22 so we
FIGURE 2. Distributions of stereo acuity for 141 normal adults from
three clinical testing sites: McGill Ophthalmology (n ¼ 46), Auckland
Optometry (n¼ 44), and Bradford Optometry (n ¼ 51).
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conclude their stereo acuity was equal to or worse than this
value. This confirms the broad distribution found in a previous
study20 of 600 normal subjects. Although both studies found a
very broad range of stereopsis, the current approach provides
more fine disparity responses consistent with its better
resolution (the previous web-based approach was limited by
pixel size).
Figure 3 shows the relationship between the measurement
means (average from the two runs) and their associated SD that
was only available for the sample of subjects tested at McGill (n
¼ 46). The best fitting line on these log/log axes is close to
unity (0.7718), suggesting the SD scales with the mean, as
expected from our staircase procedure where a relative step
size was used. The scaling factor is 0.2537 (the SD¼ 0.25373
mean) for the particular staircase parameters used here. What
this means is that, given the extent of the measurement
variability, two measurement means would be significantly
different if they were a factor of 1.9 apart. This was calculated
in the following way. Suppose in one test we find that the
threshold is Mean1 and the standard deviation SD1 equals
0.25373Mean1 and in a second test we get threshold Mean2,
which is d 3 Mean1 (d > 1) and a standard deviation SD2 of
0.2537 3 d 3 Mean1. To be able to confidently say (i.e., P <
0.05) that the threshold in the second test is larger than that
found in the first one test, the Z-score between these two tests,
which is (Mean2Mean1)/sqrt(SD12þ SD22) or rewritten as (d
 1)/0.2537/sqrt(1 þ d2), should be larger than 1.65. This will
give us a d of at least 1.9.
To assess the test–retest reliability, 90 of the subjects were
retested across the three locations. In Figure 4A, the stereo
measurements of the first test (again the average of two runs) are
plotted against those of the retest (the average of two runs). There
is a strong (r¼ 0.79) and significant (P < 0.001) correlation. In
Figure 4B, the reliability is assessed in terms of a Bland-Altman
plot with little to no bias between the two measurements (0.01)
and no significant difference (P ¼ 0.79, 2-tailed paired t-test)
between test and retest. The mean absolute difference and 95%
confidence interval was 0.01 6 0.7 log arc seconds.
Reduced Acuity and Stereo
An important issue in clinical stereo testing is the influence of
reduced vision, particularly reduced monocular vision.21,22,24
Patients may have reduced vision in just one eye, such as
amblyopes, for whom stereo performance is of particular
importance, and it is essential to know to what extent any
reduction in stereo performance is simply due to a monocular
loss of acuity. There is no way of factoring out such an acuity-
based stereo loss by altering the stimulus seen by the other
eye,24 but it is possible to measure the extent of such a
dependence and thereby know if the loss of stereopsis is of a
magnitude that would be consistent with the loss of acuity.
Figure 5B shows the effect of a monocular reduction in acuity
(due to lens blur) on stereo performance. Lens defocus of up
to 3.00 D was used, and it was verified that this did not
produce a measurable degree of aniseikonia (using the test
within the app). The solid sloping line is the best fitting line
assuming that normal stereopsis is around 6 arc seconds and
that normal acuity is 0 in logMAR (i.e., coordinate [0, 0.1]).
Results are shown for two normal subjects. The slope of the
line of best fit suggests that for every 0.1 logMAR acuity
reduction, there is a 36% loss in stereopsis. Although this was
measured for the case of monocular acuity loss, it is just as
applicable to the case of bilateral acuity loss.24
FIGURE 3. The relationship between the measurement means and
their associated SD across the sample of subjects tested in McGill (n¼
46).
FIGURE 4. Test–retest reliability. (A) Test–retest correlation. Each dot represents results of one subject; the dashed line indicates the identity line
(slope¼1). Results in the two tests are significantly correlated (r¼0.79, P < 0.001). (B) Bland-Altman difference plot. The mean difference between
the two measures (i.e., the bias), indicated by the central black dashed line, is 0.01.
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Aniseikonia and Stereo
Another issue relevant to stereopsis, and one that is rarely
considered, is aniseikonia, resulting from anisometropia
corrected with spectacles. It is generally accepted that
stereopsis requires matched images in the two eyes and that
if the retinal image size difference is too large, stereopsis will
suffer. However, image size differences between the eyes are
rarely measured, and their effects are rarely considered as a
cause of any measured stereo loss. This is an important issue
because aniseikonia rather than amblyopia may ultimately limit
the extent of benefit that can be obtained from binocular
therapy. We incorporated a method by which the interocular
image size can be measured, and the pixel display seen by the
more emmetropic eye can be adjusted to ensure any such
image size changes are factored out of the stereo assessment
(Figure 5A). Figure 5C illustrates the relationship between
stereo performance and aniseikonia (produced by scaling the
size of pixels seen by one eye) for three subjects. The sloping
line is the best fitting line assuming normal stereo of 6 arc
seconds for images of the same interocular size, (i.e., cross the
point [1, 0.1]). The slope of this line suggests that every 1%
difference in image size between the eyes results in a 33% loss
of stereopsis. This purely optical loss can be completely
compensated for in the current test by scaling the pixel size in
the more emmetropic eye, thus permitting valid measurements
of stereopsis per se.
DISCUSSION
There is a need for a convenient way to measure stereopsis in
the clinic, one that supplies a measure of variability so that valid
comparisons can be made between measurements on different
occasions and under different conditions for individuals or, in
the case of clinical trials, for populations. Here we describe a fast
(40–60 trials, taking approximately 3 minutes), convenient, and
reliable method using a handheld device based on firmly
established laboratory principles offering a compromise be-
tween laboratory accuracy and clinical utility. The random dot
stimulus offers the best way of ensuring that figural effects are
not involved. The two alternative forced choice decision is
based on the sign of the disparity that ensures the dipolar aspect
of stereo processing is respected, and the staircase measurement
method allows one to obtain a sound measure of threshold and
its variability. Equally important is the ability to measure over the
full disparity range and not just at the finest disparities, because
as we demonstrate here and elsewhere20 that there is a wide
range of stereo acuities in the general population. Our staircase
algorithm in the adult population gives an SD that is
FIGURE 5. Effect of monocular size scaling and blur on the stereo acuity. (A) Illustration of the two conditions in clinical testing: monocular acuity
loss and simulated anseikonia. (B) Stereo acuity as a function of the visual acuity in the blurred eye. Different symbols represent results of two
subjects. Error bars denote SEM. The best fitting line suggests that for every 0.1 logMAR acuity reduction, there is a 36% loss in stereopsis. The
largest defocus lens was 2 D, for which the measured degree of aniseikonia was less than 0.5% and would not have produced a significant loss of
stereo (see C). (C) Stereo acuity as a function of the interocular size ratio. Different symbols represent results of three subjects. Error bars denote
SEM. The slope of this line suggests that every 1% difference in image size between the eyes results in a 33% loss of stereopsis.
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approximately 25% of the mean, allowing a change in stereopsis
of the order of 1.9 to be statistically distinguished for individual
measurements across the whole range. This can be improved
especially in the coarse disparity range by using a staircase with
more trials and a smaller step size; however, this will mean that
the measurement will take longer, which may impact on its
clinical utility. Knowing the variance associated with individual
measurements (i.e., a measure of individual precision) is more
valid when comparing individual measurements than relying on
the confidence limits derived from a population measure such as
the test-retest analysis (i.e., a measure of population precision).
Neither measure is appropriate for comparing whether the
mean stereo of a population has changed, for example, as the
result of a particular therapy.25 In that case the distribution of
the difference between the means before and after the
treatment is important.
The test also offers the clinician the opportunity of
measuring stereopsis without contamination from image size
differences. Because this factor will affect stereo performance,
it is essential that its effect be compensated for so that valid
estimates of stereo per se can be obtained. This can be done by
altering the dimensions of each pixel in the stereo display.
Although the effect of reduced monocular or binocular acuity
can also negatively impact stereo performance, there is no way
to compensate physically for this by adjusting the stereo
stimulus. As a consequence, the size of this acuity-based loss
can be estimated so that its possible influence can be gauged,
allowing stereo losses that are much larger than the estimated
acuity-based losses to be considered as primary deficits to
binocular function per se. We assume that the low-pass effects
of defocus adequately simulate the contrast sensitivity loss
found in amblyopia.26,27
Interestingly, the subjects tested across three vision
departments did display a broad distribution, suggesting that
a substantial percentage of the population does not have fine
stereopsis. All subjects were wearing their current spectacle
prescription, so we cannot explain this broad stereo distribu-
tion on the basis of uncorrected refractive errors or indeed
undetected ocular anomalies. Furthermore, it is consistent
with a number of previous studies. Richards,28,29 using a
similar crossed versus uncrossed discrimination task, estimated
that as much as 30% of the normal population are stereo-
anomalous for this task. Hess et al.,20 using a more abbreviated
methodology (web-based, self-supervised) but on a much
larger (600) sample, found a similar large distribution of
normal stereo performance in the normal population. This
suggests it is a real effect: one that is consistent with the
authors’ experience of the difficulty of finding controls within
the general population with stereo acuity that is good enough
to participate in laboratory studies. However, it should be
noted that it is not consistent with population studies19 using
the current stereo tests that rely on a single directional depth
increment to define a particular shape. This more primitive
task does not utilize the unique bipolar nature of primate
stereo processing where separate populations of neurons are
tuned to near and far disparities.30 In fact, these two different
approaches to measuring stereopsis might not only rely on
different neuronal populations but also possibly different
cortical areas; the unipolar task that is currently used
essentially involves the discrimination of an absolute disparity,
whereas the bipolar nature of the current task involves relative
disparities. The former has been identified as occurring in area
V1 and the latter in area V2 and beyond.31
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